|
Matrixx is led by President/CEO Carl Johnson, 53, a highly qualified executive with more than 20 years experience in over-the-counter (OTC) pharmaceuticals and consumer products. From 1993 to 2001, Mr. Johnson was vice president of commercial development for Perrigo company, a public company and leading manufacturer of private label OTC drugs and nutriceuticals, where he was responsible for the procurement of new products, technologies and manufacturing services with emphasis on Abbreviated New Drug Applications (ANDA). From 1973 to 1989, Mr. Johnson was employed by Johnson & Johnson where he held a number of increasingly responsible positions in marketing and sales, including responsibility for the national launch of the Acuvue® disposable contact lenses. He also provided marketing leadership for a special Johnson & Johnson team selected to re-engineer sales, administration and operational functions. Mr. Johnson earned a Masters of Business Administration Marketing from the Farleigh Dickinson University, and a Bachelor of Science in Economics from Wagner College. Since joining Matrixx in July 2001, Mr. Johnson has spearheaded development and implementation of the company’s long-term growth strategy, including orchestration of the sale of substantially all of the company’s gum manufacturing assets and business to the Wm Wrigley Jr. Company and acquisition of the interest in Gel Tech previously owned by the company’s joint venture partner, Zensano, Inc., thereby securing full control of the proprietary Zicam® technology. | 